New drug donanemab slows cognitive decline in early Alzheimer's | New Scientist | Scooploop

You must enable Javascript to get the most out of Scooploop.

We use the latest technologies to provide the best possible web experience.

Please enable Javascript in your browser to continue.

FAQ
Scooploop Blog

New Scientist

News @SLBroadcast Mod South Bank - 1y
New drug donanemab slows cognitive decline in early Alzheimer's

The experimental treatment donanemab is now the second antibody drug to slow cognitive decline in people with early stage Alzheimer’s diseas..
https://www.newscientist.com/article/2372049-new-drug-donanemab-slows-cognitive-decline-in-early-alzheimers/?utm_campaign=RSS%7CNSNS&utm_source=NSNS&utm_medium=RSS&utm_content=home

Share on Scooploop

Share on Facebook

Share on Twitter

Share on Linkedin